Kymera Therapeutics Inc. (KYMR)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
44.15
0.02 (0.05%)
At close: Jan 23, 2025, 3:59 PM
44.23
0.18%
After-hours Jan 23, 2025, 04:00 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
Cash & Equivalents | 109.97M | 68.39M | 47.98M | 31.00M | 76.02M | 41.26M |
Short-Term Investments | 264.92M | 338.77M | 394.44M | 265.20M | 15.94M | n/a |
Long-Term Investments | 61.43M | 152.33M | 125.19M | 162.53M | 1.77M | 199.00K |
Other Long-Term Assets | 7.93M | -122.02M | -98.77M | 11.46M | n/a | n/a |
Receivables | 18.76M | 2.54M | 135.00K | 1.43M | n/a | 148.00K |
Inventory | n/a | -12.25M | -8.99M | -163.39M | n/a | n/a |
Other Current Assets | 11.67M | 9.71M | 8.72M | 4.70M | 888.00K | 382.00K |
Total Current Assets | 405.32M | 559.49M | 567.61M | 302.34M | 92.84M | 41.79M |
Property-Plant & Equipment | 101.08M | 13.33M | 11.88M | 10.84M | 22.08M | 2.24M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 170.44M | 43.64M | 38.30M | 184.84M | 23.86M | 2.44M |
Total Assets | 575.76M | 603.13M | 605.90M | 487.18M | 116.70M | 44.23M |
Account Payables | 7.08M | 4.33M | 4.00M | 4.37M | 3.28M | 2.06M |
Deferred Revenue | 37.88M | 63.26M | 101.03M | 170.39M | 23.35M | 2.32M |
Short-Term Debt | 6.34M | 7.89M | 7.20M | 6.52M | 3.38M | 302.00K |
Other Current Liabilities | 34.39M | 23.86M | 19.60M | 7.17M | 4.57M | 2.33M |
Total Current Liabilities | 85.69M | 63.26M | 101.03M | 110.62M | 34.57M | 4.69M |
Long-Term Debt | 78.33M | 26.78M | 28.73M | 29.46M | 17.82M | 393.00K |
Other Long-Term Liabilities | n/a | -13.14M | -14.30M | -14.63M | 109.08M | 73.59M |
Total Long-Term Liabilities | 95.10M | 49.72M | 45.23M | 92.67M | 156.54M | 73.98M |
Total Liabilities | 180.79M | 112.98M | 146.27M | 203.29M | 191.11M | 78.67M |
Total Debt | 84.67M | 17.34M | 17.96M | 17.99M | 21.19M | 695.00K |
Common Stock | 6.00K | 6.00K | 5.00K | 4.00K | n/a | n/a |
Retained Earnings | -530.75M | -383.79M | -228.98M | -128.76M | -76.46M | -35.21M |
Comprehensive Income | -552.00K | -4.95M | -660.00K | -128.00K | 6.00K | n/a |
Shareholders Equity | 394.97M | 490.15M | 459.64M | 283.89M | -74.41M | -34.44M |
Total Investments | 326.35M | 491.10M | 519.63M | 427.73M | 15.94M | 199.00K |